Teladoc Health Inc. ($TDOC) Stock Forecast: Up 13.5% Today

What is Teladoc Health Inc.?

Teladoc Health (TDOC.US) is a telemedicine provider offering virtual healthcare services including general medical, chronic condition management, and mental health. The company recently reported its Q1 2026 earnings, showing a slight decrease in revenue but a narrower net loss.

Why is Teladoc Health Inc. going up?

TDOC stock is up 13.5% on May 1, 2026 14:16

• Teladoc Health (TDOC) experienced a strong bullish movement as investors reacted positively to the company's Q1 2026 earnings.
• Despite a slight decrease in revenue, the significant narrowing of the net loss indicates improved cost control and efficiency within the company.
• The reaffirmation of the full-year 2026 financial outlook, along with positive free cash flow expectations, likely boosted investor confidence in Teladoc's future performance.
• Investors are closely monitoring Teladoc's ability to maintain cost discipline, stabilize growth, and capitalize on new initiatives like enhanced 24/7 Care to drive future revenue growth.

TDOC Price Chart

TDOC Technical Analysis

TDOC News

Earnings Call Summary | Teladoc Health(TDOC.US) Q1 2026 Earnings Conference

This document is an earnings call summary for Teladoc Health (TDOC.US) for their Q1 2026 earnings conference. Further details about the financial performance, key highlights, or future outlook are not provided in this entry. The document serves as a record of the earnings event.

https://www.moomoo.com/news/post/69196280/earnings-call-summary-teladoc-health-tdocus-q1-2026-earnings-conference

Teladoc Health (NYSE: TDOC) Q1 2026 revenue dips as loss narrows

Teladoc Health reported a 2% year-over-year revenue decrease to $613.8 million in Q1 2026, while its net loss narrowed significantly from $93.0 million to $63.8 million, primarily due to the absence of a prior goodwill impairment charge. The company reaffirmed its full-year 2026 financial outlook, anticipating revenue between $2.48 billion and $2.58 billion and positive free cash flow. Integrated Care segment revenue grew, but BetterHelp revenue declined, reflecting mixed performance across its services.

https://www.stocktitan.net/sec-filings/TDOC/8-k-teladoc-health-inc-reports-material-event-f40d8cb04c47.html

How Teladoc’s Slower Revenue but Narrower Losses Will Impact Teladoc Health (TDOC) Investors

Teladoc Health (TDOC) recently released its first-quarter 2026 results, showing a slight decrease in revenue to US$613.85 million but a narrower net loss of US$63.84 million. This suggests the company is improving cost control and efficiency despite softening top-line growth. Investors should watch if Teladoc can maintain cost discipline while stabilizing growth, especially with its BetterHelp platform and new initiatives like enhanced 24/7 Care.

https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/how-teladocs-slower-revenue-but-narrower-losses-will-impact

(TDOC) Teladoc Health, Inc. Expects Q2 Revenue Range $597.0M - $626.0M

Teladoc Health, Inc. announced its Q2 revenue expectations, projecting a range of $597.0 million to $626.0 million. This follows their Q1 revenue report of $613.8 million, surpassing FactSet estimates. The company, which provides virtual healthcare services including general medical, chronic condition management, and mental health, continues to release financial updates and leadership changes.

https://www.marketscreener.com/news/tdoc-teladoc-health-inc-expects-q2-revenue-range-597-0m-626-0m-ce7f58dadf8ef621

Teladoc Health, Inc. reports first quarter 2026 earnings release

Teladoc Health, Inc. has announced its financial results for the first quarter of 2026, providing key performance details for the telemedicine provider. Investors and analysts are closely scrutinizing these results amidst a competitive digital healthcare market. The company has recently expanded its offerings to include dietitian-led nutrition services and proposed a virtual care model to replace annual urgent care visits, as part of a broader strategic effort.

https://tradersunion.com/news/companies/show/1969089-teladoc-2026-earnings-results/

Trending Today

Brent Crude Oil ($BRENT) Commodity Forecast: Up 5.9% Today

Tilray Inc. ($TLRY) Stock Forecast: Down 5.1% Today

Sonos Inc. ($SONO) Stock Forecast: Down 0.8% Today

CleanSpark Inc ($CLSK) Stock Forecast: Up 5.4% Today

Digital Ocean Holdings ($DOCN) Stock Forecast: Up 5.1% Today

Circle Internet Group ($CRCL) Stock Forecast: Up 7.5% Today

Crude Oil ($CRUDE) Commodity Forecast: Up 5.0% Today

Kohl's Corporation ($KSS) Stock Forecast: Down 5.7% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 5.0% Today

Blink Charging Co. ($BLNK) Stock Forecast: Down 5.3% Today

Teladoc Health Inc. Price History

10.02.2026 - TDOC Stock was up 10.3%

• Teladoc Health's stock saw a strong bullish movement today.
• An inducement award to Daniel Conroy, the new Chief Growth Officer, U.S. Group Health, was announced under NYSE Rule 303A.08, potentially boosting investor confidence in the company's growth.
• The award, comprising restricted stock units and performance stock units tied to three-year targets, aligns Conroy's compensation with Teladoc's growth strategies, highlighting a focus on market expansion and financial performance.
• Despite a recent increase in short interest, Teladoc Health's positive developments and strategic initiatives appear to have outweighed any concerns, driving the bullish market activity.

20.03.2026 - TDOC Stock was up 5.2%

• Despite overall market gains, Teladoc Health Inc (TDOC) saw a bullish movement today.
• The company's strategic emphasis on AI integration and product portfolio enhancement likely drove this positive trend.
• Investor optimism may have been boosted by activist investor Pineal Capital Management's advocacy for a share buyback program, signaling confidence in the company's growth outlook.
• The upcoming Q1 2026 earnings report on April 29 may influence investor sentiment, with projected revenue and EPS figures shaping market expectations for Teladoc Health Inc.

01.03.2026 - TDOC Stock was up 5.6%

• Teladoc Health (TDOC) experienced a strong bullish movement today following advocacy for changes in the company's board and strategic direction by Pineal Capital, stressing a shift towards profitability and increased shareholder value.
• The appointment of Susan Salka, a veteran executive with extensive healthcare leadership and M&A experience, to Teladoc's board of directors further fueled investor optimism and confidence in the company's strategic growth prospects.
• The expansion of Hims & Hers in the personalized digital healthcare space, despite underperforming in the industry, could have indirectly contributed to positive market sentiment towards telehealth companies like Teladoc, highlighting the potential for growth and innovation in the sector.
• Overall, the combination of strategic board changes, experienced leadership appointments, and industry expansion efforts likely boosted investor confidence in Teladoc Health, driving the bullish market movement for the stock.

21.03.2026 - TDOC Stock was up 6.2%

• Teladoc Health experienced a strong bullish movement today, likely driven by several positive developments:
• The company's participation in Epic XGM 2026 to emphasize virtual care collaboration showcases its commitment to expanding healthcare services and integrating virtual care into clinical workflows, which could boost its market presence and revenue streams.
• The focus on AI integration and product innovation, along with activist investor calls for a share buyback program, indicates a strategic approach to enhancing shareholder value and driving future growth prospects.
• Personalized telehealth insights on TDOC stock could have increased investor interest and confidence in the company's long-term potential, contributing to the bullish market movement.

27.01.2026 - TDOC Stock was down 5.2%

• Teladoc Health (TDOC) witnessed a strong bearish movement despite recent positive developments and financial improvements.
• The bullish upgrade by BofA Securities and narrowing Q4 losses suggested future profitability, but caution from analysts and multiple price target reductions affected the stock.
• Analysts' conflicting signals, with some cutting forecasts despite solid financial performance, led to investor uncertainty and a bearish market trend.
• Challenges in the BetterHelp segment and declining U.S. revenues likely impacted the negative sentiment, despite positive international growth and cost-saving efforts.

01.04.2026 - TDOC Stock was up 13.5%

• Teladoc Health (TDOC) experienced a strong bullish movement as investors reacted positively to the company's Q1 2026 earnings.
• Despite a slight decrease in revenue, the significant narrowing of the net loss indicates improved cost control and efficiency within the company.
• The reaffirmation of the full-year 2026 financial outlook, along with positive free cash flow expectations, likely boosted investor confidence in Teladoc's future performance.
• Investors are closely monitoring Teladoc's ability to maintain cost discipline, stabilize growth, and capitalize on new initiatives like enhanced 24/7 Care to drive future revenue growth.

31.02.2026 - TDOC Stock was up 5.0%

• The bullish movement in Teladoc Health's stock today could be attributed to the positive market reception of Susan Salka's appointment to the board of directors.
• Susan Salka's extensive healthcare leadership and financial expertise, particularly her success in growing revenue and orchestrating acquisitions at AMN Healthcare Services, may have instilled confidence in investors regarding Teladoc Health's strategic growth potential.
• Teladoc's focus on expanding virtual care services, as evidenced by its engagement at the AONL2026 conference to enhance workforce safety and innovate through digital solutions, could have also contributed to the positive market sentiment and stock movement.
• Overall, the combination of strong leadership additions, strategic growth initiatives, and market engagement likely fueled investor optimism and drove the bullish movement in Teladoc Health's stock today.

14.03.2026 - TDOC Stock was up 5.2%

• Teladoc Health's bullish movement today can be attributed to its proactive approach in addressing gaps in rural healthcare access, as highlighted by its efforts to expand virtual diabetes prevention programs and nutrition services in underserved communities.
• The company's success with its virtual diabetes prevention program for Medicare beneficiaries likely boosted investor confidence, showcasing the effectiveness of its digital health solutions in chronic disease management.
• Positive market projections for the online doctor medical service sector, where Teladoc Health is a key player, also contributed to the bullish sentiment, indicating strong growth potential and market demand for virtual healthcare services.
• Despite ongoing investigations into potential breaches of fiduciary duties by company insiders, Teladoc Health's strategic focus on improving healthcare access and positive outcomes in chronic disease management have overshadowed these concerns, driving the stock's upward momentum.

23.02.2026 - TDOC Stock was up 2.0%

• Teladoc Health (TDOC) saw a significant bullish movement recently due to various factors:
• Despite releasing a mix of financial results and providing a cautious short-term outlook, the company raised its full-year forecast and witnessed an 8.5% increase in its user base to 101.8 million.
• Focusing on BetterHelp and chronic care, as well as expanding its platform's reach, has positively reshaped Teladoc's investment narrative, offsetting worries about competition and compliance costs.
• Investors are recognizing Teladoc's potential undervaluation, with a lower P/S ratio compared to industry peers, showing confidence in the company's growth potential in the virtual care sector.

30.03.2026 - TDOC Stock was down 9.7%

• Despite TDOC's reduced net loss and its reaffirmed full-year financial outlook, the company faced bearish market movement following the revenue decline in Q1 2026.
• Investor concerns arose due to a drop in BetterHelp revenue and a mixed performance in various services, raising questions about sustainable growth.
• The market is monitoring TDOC's cost management strategy closely, as well as its plans for future growth through innovation in products and technology investments.
• TDOC's performance in upcoming quarters may be influenced by both the competitive digital healthcare landscape and its initiatives to broaden its service offerings.

11.02.2026 - TDOC Stock was down 5.4%

• Teladoc Health's stock faced downward pressure today, despite positive developments and upgrades from analysts.
• Investor sentiment was dampened by the company's conservative outlook for upcoming periods and pessimistic earnings per share guidance for Q1 and FY2026.
• Analysts gave mixed reviews, with some raising the stock's rating based on valuation and potential exit strategies, while others remained wary of market saturation and long-term challenges.
• Following the analyst upgrades, the initial spike in share price may have been brief, as market sentiment continues to be uncertain, driven by apprehensions about profitability and insider trading activity.

27.02.2026 - TDOC Stock was down 5.3%

• Teladoc Health (TDOC) experienced a bearish movement today, underperforming the broader market, despite showing a strong climb over the past month.
• The decrease in stock price could be attributed to a price target revision from an analyst, reflecting concerns about the company's future growth and profitability.
• Analysts' revised estimates for TDOC's upcoming earnings report, anticipating a decline in EPS and revenue year-over-year, might have contributed to the negative market sentiment.
• Despite the recent dip, the long-term outlook for Teladoc Health remains positive, given the projected significant growth in the Digital Health market and the company's strategic initiatives to expand its virtual care offerings and partnerships.